ArticleThoracic cancer2026

Safety Signals of CRS and ICANS With Tarlatamab in Relapsed Small Cell Lung Cancer: Insights From a Small Case Study.

Juwhan Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.